- China
- /
- Medical Equipment
- /
- SHSE:688677
Insider-Favored Growth Stocks To Consider In December 2024
Reviewed by Simply Wall St
As global markets experience mixed performances, with major U.S. indexes reaching record highs amid a rally in growth stocks, investors are increasingly focusing on insider ownership as a potential indicator of confidence and alignment with shareholder interests. In this environment, companies where insiders hold significant stakes might offer compelling opportunities for those seeking growth, as such ownership can suggest that leaders are committed to the long-term success of their businesses.
Top 10 Growth Companies With High Insider Ownership
| Name | Insider Ownership | Earnings Growth |
| Propel Holdings (TSX:PRL) | 36.9% | 37.6% |
| SKS Technologies Group (ASX:SKS) | 32.4% | 24.8% |
| Medley (TSE:4480) | 34% | 31.7% |
| Pharma Mar (BME:PHM) | 11.8% | 56.2% |
| CD Projekt (WSE:CDR) | 29.7% | 24% |
| EHang Holdings (NasdaqGM:EH) | 32.8% | 81.5% |
| Elliptic Laboratories (OB:ELABS) | 26.8% | 111.4% |
| Fulin Precision (SZSE:300432) | 13.6% | 66.7% |
| Brightstar Resources (ASX:BTR) | 16.2% | 84.6% |
| Findi (ASX:FND) | 34.8% | 112.9% |
Let's review some notable picks from our screened stocks.
Cubic Sensor and InstrumentLtd (SHSE:688665)
Simply Wall St Growth Rating: ★★★★★★
Overview: Cubic Sensor and Instrument Co., Ltd. is a Chinese company specializing in the manufacture of gas sensors and sensor solutions, with a market capitalization of CN¥3.13 billion.
Operations: Cubic Sensor and Instrument Co., Ltd. generates its revenue through the production and sale of gas sensors and sensor solutions in China.
Insider Ownership: 10.6%
Cubic Sensor and Instrument Ltd. shows promising growth potential with revenue expected to grow 26.5% annually, outpacing the Chinese market's 13.8%. Despite a decline in net profit margin from last year, earnings are forecast to increase significantly at 44.4% per year over the next three years, surpassing the market average of 25.9%. The stock trades at a good value compared to peers but faces challenges with unsustainable dividends and high non-cash earnings levels.
- Click to explore a detailed breakdown of our findings in Cubic Sensor and InstrumentLtd's earnings growth report.
- Our expertly prepared valuation report Cubic Sensor and InstrumentLtd implies its share price may be lower than expected.
Qingdao NovelBeam TechnologyLtd (SHSE:688677)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Qingdao NovelBeam Technology Co., Ltd. focuses on the research, development, production, and sales of medical endoscopic instruments and optical products globally, with a market cap of CN¥4.61 billion.
Operations: The company generates revenue of CN¥413.02 million from the sales and maintenance of endoscopes and optical-related products.
Insider Ownership: 14.0%
Qingdao NovelBeam Technology Ltd. is poised for growth with earnings projected to rise 34.7% annually, outpacing the Chinese market's 25.9%. Revenue is also set to grow faster than the market at 29.1% per year. Despite a recent dip in sales and net income, the company maintains a competitive price-to-earnings ratio of 36.7x compared to the market average of 37x, indicating potential value for investors focused on growth prospects amidst high insider ownership levels.
- Unlock comprehensive insights into our analysis of Qingdao NovelBeam TechnologyLtd stock in this growth report.
- The valuation report we've compiled suggests that Qingdao NovelBeam TechnologyLtd's current price could be inflated.
Simplex Holdings (TSE:4373)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Simplex Holdings, Inc. offers strategic consulting, design and development, and operation and maintenance services to financial institutions, corporations, and public sectors globally with a market cap of ¥144.05 billion.
Operations: Simplex Holdings generates revenue through its strategic consulting, design and development, and operation and maintenance services provided to financial institutions, corporations, and the public sector on a global scale.
Insider Ownership: 28.7%
Simplex Holdings is positioned for significant growth, with earnings expected to increase 21.03% annually, surpassing the JP market's 7.9%. Revenue growth is forecasted at 13.6% per year, outpacing the market's 4.1%, though below the 20% high-growth threshold. Analysts project a stock price rise of 25.5%, and it trades at a substantial discount to its estimated fair value, enhancing its appeal despite a low future return on equity of 15.9%.
- Click here to discover the nuances of Simplex Holdings with our detailed analytical future growth report.
- Our comprehensive valuation report raises the possibility that Simplex Holdings is priced lower than what may be justified by its financials.
Where To Now?
- Gain an insight into the universe of 1508 Fast Growing Companies With High Insider Ownership by clicking here.
- Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
- Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Seeking Other Investments?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Qingdao NovelBeam TechnologyLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SHSE:688677
Qingdao NovelBeam TechnologyLtd
Engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide.
Solid track record with excellent balance sheet.
Market Insights
Weekly Picks
Early mover in a fast growing industry. Likely to experience share price volatility as they scale

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08
Recently Updated Narratives
Dentsply Sirona Stock: Dental Technology Built for Cycles, Not Headlines
Etsy Stock: Defending Differentiation in a World of Infinite Marketplaces
Align Technology Stock: Premium Orthodontics in a Cost-Sensitive World
Popular Narratives

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).
Early mover in a fast growing industry. Likely to experience share price volatility as they scale
